AI-generated summary
This narrative review of 12 selected articles reports that photobiomodulation may reduce lung inflammation in chronic obstructive pulmonary disease by lowering inflammatory cytokines and chemokines and raising anti-inflammatory cytokines. The authors also describe possible effects on muscle metabolism and angiogenesis. They describe PBM as a promising adjunctive option that merits further validation.
- Studies included
- 12
- Who or what was studied
- Chronic obstructive pulmonary disease (COPD) patients and related studies
- Limits stated in the abstract
- The abstract describes a narrative review, and the authors state the findings require further validation.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Inflammation, Angiogenesis. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.